Physician profile
Sandy Yee
NPI 1235807652
$4,346.85
in general payments reported to CMS, 2019-2025
15 companies · $1,382 in 2025
The $1,382 reported for 2025 was more than what 88% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $788 · 2024: $2,177 · 2025: $1,382.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,039 · Education: $308.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,038.89 |
| Education | $307.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,097.18 | 2023-2025 | |
| Janssen Biotech, INC. | $977.46 | 2023-2025 | Tremfya |
| Sun Pharmaceutical Industries INC. | $428.13 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $397.24 | 2024 | Sotyktu |
| Ucb, INC. | $388.55 | 2023-2025 | Bimzelx, Cimzia |
| Genzyme Corporation | $246.04 | 2024-2025 | |
| Arcutis Biotherapeutics, INC. | $231.17 | 2023-2025 | Zoryve |
| Regeneron Healthcare Solutions, INC. | $165.14 | 2023-2025 | Dupixent |
| Pfizer INC. | $102.58 | 2024 | |
| Novartis Pharmaceuticals Corporation | $102.37 | 2024-2025 | |
| Sanofi-Aventis U.S. LLC | $94.99 | 2024 | |
| Lilly USA, LLC | $61.55 | 2024-2025 | Taltz, Ebglyss, Olumiant |
| Incyte Corporation | $24.63 | 2025 | Opzelura |
| Genentech USA, INC. | $21.07 | 2024 | Xolair |
| Organon LLC | $8.75 | 2025 | Vtama |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandy Yee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.